These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 14579780

  • 1. Chemokine receptor antagonists from discovery to the clinic.
    Horuk R.
    Ernst Schering Res Found Workshop; 2004; (44):169-90. PubMed ID: 14579780
    [No Abstract] [Full Text] [Related]

  • 2. Chemokines.
    Horuk R.
    ScientificWorldJournal; 2007 Feb 19; 7():224-32. PubMed ID: 17334613
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z, Schwarz M, Power CA, Wells TN, Proudfoot AE.
    Trends Immunol; 2005 May 19; 26(5):268-74. PubMed ID: 15866240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial chemokines in autoimmune disease.
    Christopherson KW, Hromas RA.
    Curr Pharm Des; 2004 May 19; 10(2):145-54. PubMed ID: 14754394
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, Trapp BD, Rao A, Ransohoff RM.
    J Neuroimmunol; 2002 Jul 19; 128(1-2):16-22. PubMed ID: 12098506
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The clinical potential of chemokine receptor antagonists.
    Ribeiro S, Horuk R.
    Pharmacol Ther; 2005 Jul 19; 107(1):44-58. PubMed ID: 15894378
    [Abstract] [Full Text] [Related]

  • 12. Strategies for chemokine antagonists as therapeutics.
    Proudfoot AE, Power CA, Rommel C, Wells TN.
    Semin Immunol; 2003 Feb 19; 15(1):57-65. PubMed ID: 12495641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chemokines and their receptors in infectious disease.
    McDermott DH, Murphy PM.
    Springer Semin Immunopathol; 2000 Feb 19; 22(4):393-415. PubMed ID: 11155443
    [No Abstract] [Full Text] [Related]

  • 17. The progress of chemokines and chemokine receptors in autism spectrum disorders.
    Ye J, Wang H, Cui L, Chu S, Chen N.
    Brain Res Bull; 2021 Sep 19; 174():268-280. PubMed ID: 34077795
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R, Mrugacz M, Bakunowicz-Łazarczyk A.
    Klin Oczna; 2007 Sep 19; 109(7-9):345-8. PubMed ID: 18260295
    [Abstract] [Full Text] [Related]

  • 20. Chemokine signaling defines novel targets for therapeutic intervention.
    Rodríguez-Frade JM, Martínez-A C, Mellado M.
    Mini Rev Med Chem; 2005 Sep 19; 5(9):781-9. PubMed ID: 16178721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.